Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Sh. F. Erdes"'
Autor:
V. I. Mazurov, Sh. F. Erdes, I. Z. Gaydukova, T. V. Dubinina, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, E. P. Ilivanova, A. V. Strelkova, V. V. Tyrenko, E. A. Mikhailova, A. V. Eremeeva
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 35-46 (2024)
The article presents the results of the three-year use of netakimab (NTK) in patients with ankylosing spondylitis (AS) as part of the phase III BCD-085-5/ASTERA study.Objective: to evaluate the long-term efficacy and safety of NTK over a three-year p
Externí odkaz:
https://doaj.org/article/35b1cb81150247aab4f58712cc2503b9
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 109-116 (2024)
Hip joint inflammation (coxitis) occurs in almost half of patients with ankylosing spondylitis (AS) and often leads to early disability. A therapy for this condition has not yet been developed, although it is one of the indications for the initiation
Externí odkaz:
https://doaj.org/article/2e3da644a4d54dd083779e5132196888
Autor:
T. V. Dubinina, A. B. Demina, E. M. Agafonova, Sh. F. Erdes, V. I. Mazurov, I. Z. Gaydukova, A. M. Pristrom, E. V. Kunder, N. F. Soroka, A. A. Kastanayan, T. V. Povarova, E. S. Zhugrova, T. V. Plaksina, P. A. Shesternya, T. V. Kropotina, O. V. Antipova, E. A. Smolyarchuk, O. A. Tsyupa, D. I. Abdulganieva, S. A. Lapshina, D. G. Krechikova, I. G. Gordeev, O. B. Nesmeyanova, V. V. Tyrenko, E. P. Ilivanova, A. V. Strelkova
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 52-58 (2023)
The article contains the data obtained during the 156-week follow-up of patients with ankylosing spondylitis (AS) in the ASTERA phase III study.Objective: to evaluate the effect impact of netakimab (NTK) on quality of life (QoL), back pain and work c
Externí odkaz:
https://doaj.org/article/21939fb7c39048f99cdce239380dea45
Autor:
Sh. F. Erdes, K. V. Sakharova
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 61-66 (2023)
The link between the HLA-B27 gene and ankylosing spondylitis (AS) has been known for almost 50 years. During this time, it has been discovered that some of the clinical manifestations of the disease are uniformly associated with the disease in almost
Externí odkaz:
https://doaj.org/article/2f5a1c77185842b58e1d42ea12ea2d4e
Publikováno v:
Современная ревматология, Vol 17, Iss 4, Pp 7-12 (2023)
Coxitis is one of the characteristic clinical manifestations of ankylosing spondylitis (AS). Hip joint (HJ) involvement in AS is considered an un-favorable prognostic factor. Early detection of coxitis is of great importance, since with the timely in
Externí odkaz:
https://doaj.org/article/1a3f5750a60b43b983e2d6ba70200939
Publikováno v:
Современная ревматология, Vol 17, Iss 3, Pp 30-36 (2023)
The “Treat-to-target” (T2T) strategy for axial spondyloarthritis (axSpA) has made it possible to optimize therapy in most patients, but in some of them the treatment goals are not achieved.Objective: to analyze the clinical features of patients w
Externí odkaz:
https://doaj.org/article/bba8a931156345ea95db8632ffada904
Autor:
Sh. F. Erdes, A. S. Starkova
Publikováno v:
Современная ревматология, Vol 17, Iss 2, Pp 82-85 (2023)
Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) is a concern for both doctors and patients. However, in axial spondyloarthritis (axSpA), NSAIDs are used not only as a symptomatic therapy, but also to prevent the progression of the dis
Externí odkaz:
https://doaj.org/article/9c13c48ec9954cd09604fea1c1f646a3
Autor:
Sh. F. Erdes
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 3, Pp 267-270 (2022)
The 2019 coronavirus disease pandemic (COVID-19) is particularly challenging not only for doctors, but also for patients with inflammatory diseases, including spondyloarthritis. Although a large number of studies have been conducted over the past 2 y
Externí odkaz:
https://doaj.org/article/091d8586d2a747b0a5dbcd5f7d8e04ed
Autor:
Sh. F. Erdes, B. S. Belov
Publikováno v:
Современная ревматология, Vol 17, Iss 1 (2023)
The review analyzes data on the course and outcomes of axial spondyloarthritis (axSpA) accumulated over the previous 2.5 years of the COVID-19 pandemic. The issues of clinical and immunological efficacy of vaccination against COVID-19 in this disease
Externí odkaz:
https://doaj.org/article/cf3098012ec74436be96535c3ccfaaab
Publikováno v:
Современная ревматология, Vol 15, Iss 6, Pp 67-71 (2021)
Spine involvement in ankylosing spondylitis (AS) resulting in limited mobility requires a search for accurate, quantitatively methods of assessment of the decline of its function and monitoring of its dynamics. One of the promising methods for assess
Externí odkaz:
https://doaj.org/article/a30ee2fc5157473b9eee2a00ca8be8b3